Kirkland & Ellis represented Bain Capital Tech Opportunities in the transaction.
Pinheiro Guimarães advised Bionexo S.A. and selling shareholders.
Bain Capital Tech Opportunities finalized its agreement to make a R$450 million growth investment in Bionexo, a leading Latin American cloud software and data analytics provider that connects healthcare suppliers and providers. The funding will enable Bionexo to rapidly expand its suite of healthcare SaaS platforms, pursue transformational M&A opportunities and further consolidate its category-leading position. Bain Capital Tech Opportunities will join Bionexo’s existing investors including Prisma Capital, Apus and Temasek in supporting the growth of the company.
Bain Capital Tech Opportunities aims to help growing technology companies reach their full potential.
The Kirkland team was led by corporate partner Chris Elder (Picture) and associate Neil Vohra and included corporate partner Matthew O’Brien and tax partners Mike Carew and Christine Lehman.
Pinheiro Guimarães assisted Bionexo S.A., as target; and Maurício de Lazzari Barbosa, Apus Participações S.A., Prisma Bazar Fundo de Investimentos em Participações Multiestratégia, Orjen Investments PTE. Ltd., as controlling shareholders, and other minority shareholder, with a team led by partners Bernardo Bulhões (Picture) and Francisco José Pinheiro Guimarães, and associates Bernardo Romano Teixeira and Julia Machado Barreto.
Involved fees earner: Mike Carew – Kirkland & Ellis; Christopher Elder – Kirkland & Ellis; Christine Lehman – Kirkland & Ellis; Matthew O’Brien – Kirkland & Ellis; Neil Vohra – Kirkland & Ellis; Bernardo Bulhões – Pinheiro Guimarães; Julia Machado Barreto – Pinheiro Guimarães; Francisco José Pinheiro Guimarães – Pinheiro Guimarães; Bernardo Romano Teixeira – Pinheiro Guimarães;